Synapsoft logo
AI Insights from Disclosures
Searching...
FutureChem Co., Ltd. 220100
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
FutureChem Co., Ltd. engages in the new drug development business for radiopharmaceuticals, which researches and develops peptide compounds similar to proteins specifically expressed in certain diseases, labels them with radioisotopes, and uses them to diagnose and treat specific diseases. Unlike general pharmaceuticals, in radiopharmaceuticals the diagnostic and therapeutic role is played by the radioisotope, while the peptide, which has a molecular structure similar to PSMA, only performs the role of a tracer that finds its way to cancer cells.
Representative Director Ji Daeyun
Founded August 13, 2001
Corporation Type KOSDAQ
Industry Classification Manufacture of medicaments
Corporate number 12461-0260311
Business number 121-81-46715
Phone Number 02-497-3114
Fax Number 02-3010-8516
Company Address 26 Seongsuil-ro 10-gil, Seongdong-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant